openPR Logo
Press release

Over-The-Counter Pain Medication Market is expected to reach a valuation of US$ 27.7 billion by the end of 2028 | FMI

09-28-2022 02:43 PM CET | Health & Medicine

Press release from: Future Market Insights

Over-The-Counter Pain Medication Market is expected to reach

[Report of 274 pages] Over-the-counter pain medication currently generates a revenue of US$ 21.8 billion in 2022 and is expected to reach a valuation of US$ 27.7 billion by the end of 2028. Over-the-counter pain medication demand is expected to grow at a CAGR of 4.1% from 2022 to 2028.

The OTC (over-the-counter) pain medication market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic pharmaceutical drugs, according to a recent study published by Future Market Insights (FMI). The study opines that market revenue will rev up at an improved rate of 3.7% to exceed US$ 19.3 billion in 2019. FMI analyzes various aspects of market growth influencing the OTC pain medication market.

To remain ahead of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-8947

Many consumers are making a shift to generic drugs to reduce total spending on non-prescription or OTC pain medication. Various governing bodies, such as the United States Food and Drug Administration (FDA), have implemented stringent regulations and labeling rules to ensure the safety and effectiveness of OTC pain medications. Leading players in the OTC pain medication market are collaborating with generic drug-makers to capitalize on the trend of consumer inclination towards generic versions of branded OTC pain medications, finds FMI.

The FMI study features valuable and actionable insights obtained through thorough research on OTC pain medication market. Some of the insights mentioned in the study are,

Growing geriatric population and prevalence of chronic pain-related disorders among the elderly population is bolstering sales of OTC pain medications.
Over 20% of the adult population of the world is already suffering from pain-related disorders and new cased of pain-related problems are reported by over 10% of the global population, which is increasing significantly every years. This is providing an impetus to growth of the OTC pain medication market.
Increasing awareness about the side effects of pain killers, such as stomach ulcers and gastrointestinal problems, may hamper the OTC pain medication market growth.

Developed countries will dominate the OTC pain medications market with more than half the revenue share of the market. However, developing countries in Southeast Asia will witness fastest growth in the OTC pain medication market with rapidly developing pharmaceuticals and healthcare sector in the region.

Acetaminophen Drugs Hold Majority Share in OTC Pain Medication Market

The FMI study thoroughly assesses growth of the OTC pain medication market based on various drug classes, such as Nonsteroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and local anesthetics. The study finds that acetaminophens are among the most commonly purchased OTC pain medication, and this drug class holds 45% share in the revenues of OTC pain medication market. As acetaminophen is considered as a safer pain medication than other pain relievers, its demand will continue to remain high in the upcoming years, opines the FMI study.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert - https://www.futuremarketinsights.com/ask-question/rep-gb-8947

The Consumer Healthcare Products Association (CHPA), an American trade association, recently published a study on the misuse of acetaminophen-based OTC combination products. The study found that a 28 percent decline was recorded in therapeutic misuse exposures involving acetaminophen-containing OTC combination products. The incidents of acetaminophen misuse decreased from 8,753 to 6,278 between 2007 and 2016, which is a substantial evidence for the safety and effectiveness of acetaminophen-containing OTC pain medications.

Thereby, the FMI study opines that the acetaminophen drugs will maintain a maximum share of over US$ 8.7 billion in the OTC pain medication market through 2019, and the trend will continue to persist in the coming future.

Governments take Initiatives to Spread Awareness about Safe Use of OTC Pain Medications

Despite the increasing reliance on OTC pain medications, a large consumer group is still skeptical about their effectiveness and positive impacts on health. In order to help consumers to avoid incorrect use of OTC pain medications, many governing bodies including FDA have developed guidelines and tips for patients for choosing appropriate OTC pain medications. Consumers are becoming conscious about the drug fact labeling (DFL) requirements and other regulations vis-à-vis OTC pain medications, which is influencing major dynamics of the OTC pain medication market, projects the FMI study.

The study provides a futuristic overview of the OTC pain medication market with important information about growth prospects of the market during the forecast period 2018-2028. The study predicts that the OTC pain medication market will witness healthy growth at a healthy 4.5% value CAGR to reach US$ 13 billion by the end of the assessment period.

For in-depth competitive analysis, Buy Now - https://www.futuremarketinsights.com/checkout/8947

Key Segment

Based on drug class

non-steroidal anti-inflammatory drugs (NSAIDs)
local anaesthetics
acetaminophen
Based on route of administration

oral
tropical
others
Based on dosage from

tablets
capsules
creams
gels
others
Based on distribution channels

hospital pharmacies
drug stores
retail stores
e-commerce
others

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Over-The-Counter Pain Medication Market is expected to reach a valuation of US$ 27.7 billion by the end of 2028 | FMI here

News-ID: 2752342 • Views:

More Releases from Future Market Insights

Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fueled by demand for smart diagnostics and medical R&D.
Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fu …
The global electronic tongue market is advancing rapidly, poised to reach USD 497.9 million in 2025 and climb to USD 774.2 million by 2035, growing at a promising 4.5% CAGR. The increasing demand for precision diagnostics, pharmaceutical quality control, and personalized medicine is driving this technological surge, positioning the electronic tongue as a futuristic, non-invasive diagnostic instrument in healthcare and pharmaceuticals. Electronic tongues, by design, mimic human sensory functions through an
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at 4.5% CAGR with strong electronics and aerospace demand.
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at …
The global market for ESD (electrostatic discharge) tapes and labels is entering a new decade of expansion driven by technological innovation, the rise of miniaturized electronics, and heightened quality standards in manufacturing. Valued at USD 2,738.8 million in 2025, the market is expected to reach USD 4,253.3 million by 2035, expanding at a steady 4.5% CAGR. This reflects a world increasingly dependent on efficient anti-static solutions that ensure the protection
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sustainable innovations and expanding applications.
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sust …
The global market for catalase is preparing for steady long-term expansion, driven by green chemistry, renewable sourcing, and biotechnology-driven production upgrades. Projected to reach USD 424.5 million in 2025 and USD 575.9 million by 2035, the industry's 3.1% CAGR reflects its broadening influence across critical sectors including food and beverages, pharmaceuticals, textiles, and personal care. With growing concerns about sustainability, efficiency, and safety, catalase is emerging as a vital biocatalyst
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled by natural, functional, and sustainable trends.
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled …
The global Quillaia extract market is entering a period of unprecedented growth, reflecting the world's shift toward natural, functional, and nutrient-rich ingredients. Projected to increase from USD 1,039.6 million in 2025 to USD 1,826.9 million by 2035 at a robust 5.8% CAGR, the industry's future is shaped by consumer demand for healthier, eco-friendly products and manufacturers' determination to stay ahead through innovation, expansion, and diversification. Over the past few years, Quillaia

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to